Clear-Cell Renal-Cell Carcinoma (ccRCC) Clinical Trials in Chicago, Illinois

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body